COVID vaccine safety data for children ‘extremely reassuring’ A new study tracking nearly 400,000 children aged 5–15 post-vaccination found adverse events were generally short-term and mild.
TGA green lights Nuvaxovid for 12–17-year-olds But while provisional approval has been granted, inclusion in the national program for this age group is yet to be confirmed.
Slight rise in adverse reactions for joint COVID and flu jabs A peer-reviewed article looking at the co-administration of COVID booster and flu vaccines in the US reports that most reactions tend to be mild.
Supply issues flagged as TGA provisionally approves Moderna for under-fives The Federal Health Minister has urged parents to delay booking COVID vaccine appointments for their very young children.
Awards will support risk-benefit analysis of COVID vaccination in kids A newly funded project will evaluate how risk communication for vaccines can be improved to boost vaccine uptake among children.
No plans for fourth COVID-19 vaccine dose for GPs The Department of Health has indicated that healthcare workers are more at risk of getting COVID-19 in the community than at work.
Australia records fifth Japanese encephalitis death The latest confirmed death has prompted health authorities to remind GPs of their role in vaccination uptake.
Flu jab ‘helped workers avoid COVID-19’: Study A new pre-print article looking at healthworkers in Qatar suggests those who had a flu jab stood a much better chance of dodging severe COVID-19.
What do rising COVID-19 case numbers mean for GPs? Cases and deaths are many times the amount modelled ahead of Australia’s re-opening – although there has been surprisingly little discussion.
COVID-19 advice translated into 15 languages Information is now available through healthdirect in a variety of commonly spoken languages covering multiple aspects of managing the disease.